JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms

被引:0
作者
Maslah, N. [1 ]
Roux, B. [2 ]
Kaci, N. [2 ]
Verger, E. [1 ]
De Oliveira, R. Daltro [3 ]
Pasquer, H.
Zhao, L. P. [4 ]
Gauthier, N. [3 ]
Soret-Dulphy, J. [3 ]
Ganesan, S.
Gou, P. [5 ]
Ling, F.
Parquet, N. [4 ]
Vainchenker, W. [4 ]
Raffoux, E. [4 ]
Padua, R. A. [5 ]
Giraudier, S. [1 ]
Puissant, A. [2 ]
Lobry, C. [2 ]
Kiladjian, J. J. [3 ]
Cassinat, B. [1 ]
Benajiba, L. [3 ]
机构
[1] Univ Paris Cite, Hop St Louis, APHP, Lab Biol Cellulaire, Paris, France
[2] Inst Rech St Louis, INSERM UMR 944, Paris, France
[3] Univ Paris Cite, Hop St Louis, APHP, Ctr Invest Clin,INSERM CIC 1427, Paris, France
[4] Univ Paris Cite, Hop St Louis, APHP, Dept Hematol & dImmunol, Paris, France
[5] Inst Rech St Louis, INSERM UMR 1131, Paris, France
关键词
clonal selection; JAK2; inhibition; myelopro-liferative neoplasms; RAS mutations; ruxolitinib;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CO-008
引用
收藏
页码:11 / 11
页数:1
相关论文
共 3 条
[1]   JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis [J].
Harrison, Claire ;
Kiladjian, Jean-Jacques ;
Al-Ali, Haifa Kathrin ;
Gisslinger, Heinz ;
Waltzman, Roger ;
Stalbovskaya, Viktoriya ;
McQuitty, Mari ;
Hunter, Deborah S. ;
Levy, Richard ;
Knoops, Laurent ;
Cervantes, Francisco ;
Vannucchi, Alessandro M. ;
Barbui, Tiziano ;
Barosi, Giovanni .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :787-798
[2]   Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia [J].
McMahon, Christine M. ;
Ferng, Timothy ;
Canaani, Jonathan ;
Wang, Eunice S. ;
Issette, Jennifer J. D. Morr ;
Eastburn, Dennis J. ;
Pellegrino, Maurizio ;
Durruthy-Durruthy, Robert ;
Watt, Christopher D. ;
Asthana, Saurabh ;
Lasater, Elisabeth A. ;
DeFilippis, RosaAnna ;
Peretz, Cheryl A. C. ;
McGary, Lisa H. F. ;
Deihimi, Safoora ;
Logan, Aaron C. ;
Luger, Selina M. ;
Shah, No P. ;
Carroll, Martin ;
Smith, Catherine C. ;
Perl, Alexander E. .
CANCER DISCOVERY, 2019, 9 (08) :1050-1063
[3]   Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms [J].
Vainchenker, William ;
Kralovics, Robert .
BLOOD, 2017, 129 (06) :667-679